← Open Payments lookup

PAULA BLAND: Open Payments

NPI 1902322787 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$665 in 27 payments from 14 companies in 2025. Trend: 2023 $774 · 2024 $867 · 2025 $665

Food & beverage: $665
CompanyPaymentsAmount
Novo Nordisk Inc7$195
Axsome Therapeutics, Inc.3$152
ABBVIE INC.5$90
Novartis Pharmaceuticals Corporation2$39
PFIZER INC.1$25
Eisai Inc.1$24
Boston Scientific Corporation1$22
Takeda Pharmaceuticals U.S.A., Inc.1$20
Lilly USA, LLC1$20
Esperion Therapeutics, Inc.1$18

Products named: Ozempic, Auvelity, UBRELVY, LEQVIO, QULIPTA, PREVNAR 20, Leqembi, WATCHMAN Access System.

Industry payments across MS — which companies pay providers there.